## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 20 ml methanol. At room temperature, 1 mol/L sodium acetate solution was slowly added dropwise with stirring until the pH achieving 4.5. The product was sampled and analyzed. HPLC purity was determined as 99.53%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 20 ml isopropanol. At room temperature, 0.5 mol/L sodium sulfite solution was slowly added dropwise with stirring until the pH achieving 5.5. The product was sampled and analyzed. HPLC purity was determined as 99.48%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 20 ml n-propanol. At room temperature, 0.3 mol/L sodium hydrosulfide solu› tion was slowly added dropwise with stirring until the pH achieving 6.0. The product was sampled and analyzed. HPLC purity was determined as 99.38%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 5 ml sec-butanol. At room temperature, 0.1 mol/L mixture solution of sodium butyrate and sodium isobutyrate (molar ratio being 1: 1) was slowly added dropwise with stirring until the pH achieving 4. The product was sampled and analyzed. HPLC purity was determined as 99.53%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 20 ml tert-butanol. At room temperature, 0.5 mol/L disodium hydrogen phos› phate solution was slowly added dropwise with stirring until the pH achieving 6.0. The product was sampled and analyzed. HPLC purity was determined as 99.40%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.25 g of compound of formula I obtained from Example 1 was dissolved in 20 ml purified water and 20 ml n-butanol. At 

## Example 8 

## Example 9 

## Example 10 

## Example 11 

## Example 12 

## Example 13 

room temperature, 0.5 mol/L sodium borate solution was slowly added dropwise with stirring until the pH achieving 6.5. The product was sampled and analyzed. HPLC purity was determined as 99.30%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.22 g of compound of formula I from Example 1 was dissolved in 20 ml purified water and 20 ml ethanol. At room temperature, 0.4 mol/L mixture solution of mono sodium suc- cinate, disodium succinate and sodium tartrate (molar ratio being 1 : 1 : 1) was slowly added dropwise with stirring until the pH achieving 4.0. The product was sampled and analyzed. HPLC purity was determined as 99.53%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.22 g of compound of formula I from Example 1 was dissolved in 20 ml purified water and 20 ml methanol. At room temperature, 0.05 mol/L mixture solution of sodium bicarbonate and sodium acetate (molar ratio being 1: 1) was slowly added dropwise with stirring until the pH achieving 4.5. The product was sampled and analyzed. HPLC purity was determined as 99.54%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.22 g of compound of formula I from Example 1 was dissolved in 20 ml purified water and 20 ml methanol. At room temperature, 0.2 mol/L mixture solution of sodium sorbate and sodium malate (molar ratio being 1: 1) was slowly added dropwise with stirring until the pH achieving 4.0. The product was sampled and analyzed. HPLC purity was deter› mined as 99.49%. 

## Preparation for Micafungin Sodium (Compound of Formula II) 

0.22 g of compound of formula I from Example 1 was dissolved in 20 ml purified water and 20 ml methanol. At room temperature, 0.2 mol/L mixture solution of sodium propionate and sodium benzoate (molar ratio being 1: 1) was slowly added dropwise with stirring until the pH achieving 4.0. The product was sampled and analyzed. HPLC purity was determined as 99.52%. 

Descriptions hereinbefore are merely preferable examples and these examples are not to limit the scope of the Invention. The virtual technical content of the present invention is broadly defined in the claims sought for protection of the present invention. Should any technical entity or method accomplished by anyone else be equivalent to the scope of protection defined by the present invention, it shall be deemed as an equivalent substitution, all of which shall be deemed as encompassed in the scope of claims of the present invention. 

## Example 14 

## Example 15 

## Example 16 

## Example 17 

